Abstract
The presentation and identification of cardiovascular disease in women pose unique diagnostic challenges compared to men, and underrecognized conditions in this patient population may lead to clinical mismanagement.This article reviews the sex differences in cardiovascular disease, explores the diagnostic and prognostic role of cardiovascular magnetic resonance (CMR) in the spectrum of cardiovascular disorders in women, and proposes the added value of CMR compared to other imaging modalities. In addition, this article specifically reviews the role of CMR in cardiovascular diseases occurring more frequently or exclusively in female patients, including Takotsubo cardiomyopathy, connective tissue disorders, primary pulmonary arterial hypertension and peripartum cardiomyopathy. Gaps in knowledge and opportunities for further investigation of sex-specific cardiovascular differences by CMR are also highlighted.
| Original language | English |
|---|---|
| Article number | 71 (2020) |
| Number of pages | 17 |
| Journal | Journal of Cardiovascular Magnetic Resonance |
| Volume | 22 |
| DOIs | |
| Publication status | Published - 28 Sept 2020 |
Research Groups and Themes
- Bristol Heart Institute
Keywords
- cardiovascular magnetic resonance
- female cardiovascular disesase
- ischemic heart disease
- non-ischemic cardiomyopathies
- peripartum cardiomyopathy
- chemotherapy-induced cardiomyopathy
- congenital heart disease
- Turner syndrome
- connective tissue disease
- pulmonary hypertension
Access to Document
- Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via BMC at https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-020-00666-4 . Please refer to any applicable terms of use of the publisher.